Swab‐Derived Viral Load as a Biomarker of Tumor Biology in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma
Head & Neck · 2026
DOI: 10.1002/hed.70296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Ella P Jackert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Viral Load, Carcinoma, Squamous Cell, Papillomavirus Infections. Die Arbeit nennt 48 Literaturangaben. Gefördert von: American Cancer Society, USC Office of Research and Innovation, American Association for Cancer Research.
Abstract (Originalsprache)
Introduction
Site‐specific identification of human papillomavirus (HPV)‐driven oropharyngeal squamous cell carcinoma (HPV+ OPSCC) remains a major diagnostic challenge. We developed a site‐directed mucosal swab assay designed to detect and quantify tumor‐derived HPV DNA shed into the oropharyngeal surface overlying HPV‐associated tumors.
Methods
Patients with biopsy‐proven HPV+ OPSCC or oral cavity SCC as controls were enrolled after providing informed consent. Swabs of the tumor site as well as the contralateral normal mucosa were collected. Swab‐derived DNA was extracted and analyzed by quantitative PCR targeting HPV16 and HPV genotyping with Sanger sequencing. Multivariable linear regression models were used to evaluate associations between swab‐based viral load and clinicopathologic features.
Results
In a prospective cohort of 30 patients with HPV+ OPSCC, tumor‐side swabs detected HPV DNA in 30 of 30 cases. Swabs obtained from the contralateral mucosa showed substantially lower HPV DNA levels, demonstrating strong spatial specificity for the tumor‐bearing region. The assay limit of detection was determined to be ~10 HPV16 copies per reaction (1 viral genome per 500 diploid cells). All negative control patients with oral cavity SCC had negative results. Regression models revealed node‐positive status to be independently associated with low quantitative HPV16 viral load (fold change = 0.013, 95% CI: 0.001–0.178).
Conclusions
By enabling minimally invasive, anatomically targeted detection of HPV‐driven cancer at the primary site, this swab‐based assay has the potential to shorten the diagnostic pathway for HPV+ OPSCC while providing quantitative viral load measurements that may serve as a surrogate biomarker for intratumoral biology in HPV+ OPSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, California, USA.
- Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA.
- Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Ella P Jackert, Daniel Kwon, Niels Kokot, Uttam Sinha, Albert Y Han
Förderung
- American Cancer Society
- USC Office of Research and Innovation
- American Association for Cancer Research
- Office of Research and Innovation, University of Southern California
Zitieren
APA
Jackert, E. P., Koh, M., Vimawala, S., Tang, L., Kwon, D., Kokot, N., St John, M., Chai, Y., Sinha, U., & Han, A. Y. (2026). Swab‐Derived Viral Load as a Biomarker of Tumor Biology in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.70296
Vancouver
Jackert EP, Koh M, Vimawala S, Tang L, Kwon D, Kokot N, et al. Swab‐Derived Viral Load as a Biomarker of Tumor Biology in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma. Head & Neck. 2026. doi:10.1002/hed.70296
BibTeX
@article{Jackert2026,
author = {Jackert, Ella P and Koh, Michelle and Vimawala, Swar and Tang, Liyang and Kwon, Daniel and Kokot, Niels and St John, Maie and Chai, Yang and Sinha, Uttam and Han, Albert Y},
title = {Swab‐Derived Viral Load as a Biomarker of Tumor Biology in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70296}
}
EUVIMED